Article

CURE®’s Top Stories: September 2020

Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for September 2020.

Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for September 2020.

5. Premenopausal Women Facing Increased Ovarian Cancer Risk Favor Removing Fallopian Tubes But Saving Ovaries

A recent study has found that most premenopausal women planning preventive surgery because of a predisposition to ovarian cancer would prefer to remove only their fallopian tubes, putting off removal of their ovaries until they reach menopause.

4. Overuse of Antibiotics Could Be Linked to Rise in Early-Onset Colorectal Cancer, According to One Expert

In this video interview, Dr. Mark Lewis discusses current investigation of the idea that the rise of early-onset colorectal cancer could be related to the overuse of antibiotics in childhood.

3. The Latest News and Updates in Prostate Cancer

With several updates in the field of prostate cancer having happened in recent weeks, this CURE® roundup looks back at some of the latest news affecting patients with this disease.

2. Supreme Court Justice Ruth Bader Ginsburg Dies From Cancer

Here, we take a look back at the life of Supreme Court Justice Ruth Bader Ginsburg, who died on Friday, Sept. 18, 2020, after five bouts with cancer.

1. Oncology Nurses Have A Love for Healing

In this nomination essay for the 2020 Extraordinary Healer award for oncology nursing, patient Timothy Green recounts how his oncology nurse's love for healing helped him on his treatment journey.

Thank you for reading!

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
image of serzan.
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
Image of two doctors with text.
Image of doctors with text.
Imiage of two doctors with text.
Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma
Image of two doctors and text.
Image of patient and doctor.
Image of two doctors with text.
Related Content